GSK sells rabies and ticks vaccines for nearly €1bn
The Aquafresh and Panadol drugs business GSK has sold two of its travel vaccines for up to €955 million, the company has announced.
GSK said it will receive an upfront payment of €301m with the rest depending on certain sales targets being hit.
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





